Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication
of the un-audited (Standalone & Consolidated) financial results for the 2nd quarter and half-year ended 30th September 2023 published on 08th November 2023 in Financial Express(English) and Navatelangana (Telugu).
Krishna Institute of Medical Sciences Results Earnings Call for Q2FY24
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript. Q2FY24 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Healthcare Facilities company Krishna Institute of Medical Sciences announced Q2FY24 results: Gross revenue at Rs 655 crore, a growth of 14.3% on a YoY and 7.6% on a QoQ basis. Reported Operating EBITDA of Rs 180 crore, an increase of 11.5% YoY and 12.5% QoQ basis. Reported EBITDA margin at 27.5% vs. 28.3% in Q2FY23 and 26.3% in Q1FY24. PAT at Rs 101 crore in Q2FY24 against Rs 91 crore (before one-offs) and Rs 87 crore in Q2FY23 and Q1FY24 respectively. Conducted 4.13 lakhs OPD consults in Q2FY24, up by 10% on YoY and 8% on QoQ basis. Bed occupancy in Q2FY24 at 76.4%, up by 3.8% on YoY and 6% QoQ basis. ARPOB at Rs 31,140 in Q2FY24, 6.5% growth YoY and marginal decline of 1.8% on QoQ basis. Cash and Cash Equivalents at Rs 104 crore in Q2FY24. Net Debt to Equity ratio at 0.26. Announcing Q2FY24 results, Dr. B Bhaskar Rao, CMD, KIMS Hospitals, said, "The second quarter has been a busy one for us. We have seen patient footfalls steadily increasing at all our centers. I am particularly pleased to see that our clinical additions in the newly acquired units (Sunshine & Nagpur) have resulted in an uptick in performances across all fronts. Our expansion plans at Bangalore, Nashik and Mumbai are progressing as per schedule. I am optimistic that we are on track to achieve our targets for FY24. Result PDF
KIMS Hospitals Q2 results: Net profit falls 4.5% to Rs 101 crore
The hospital operator's revenue for the quarter came in at Rs 655 crore, reflecting a 14.3 percent rise YoY from Rs 573 crore in the year-ago period. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. Shantanu Rastogi as Non-Executive & Non-Independent Director of the Company. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release for the un-audited quarter and half yearly results for the period ended 30.09.2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation Krishna Institute of Medical Sciences Ltd - 543308 - Unaudited Financial Results For The Quarter And Half Yearly Ended 30.09.2023
unaudited financial results for the quarter and Half Yearly ended 30.09.2023 Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Approval Of Unaudited Quarterly And Financial Results For The Quarter And Half Yearly Ended 30.09.2023
Approval of unaudited Quarterly and financial results for the quarter and half yearly ended 30.09.2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Call on 08.11.2023